‘The conditions are ripe’: industry says it’s time for feds to consider a national bioeconomy strategy
Canada once had a biotechnology strategy that, despite its flaws and poor execution, sent a signal that biotech firms should open up shop in Canada.
With Canada’s biotechnology sector showing signs of new growth, industry advocates say it’s time the federal government consider a national biotech strategy, more than a decade after one created in 1998 was nixed by the Conservative government.
SPONSORED CONTENT
Get Mondays: Environment Newsletter
From climate change to natural resources, dive into environmental legislation, policy, and advocacy.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
